Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,241 total articles
SoFi reported a strong Q2 with $1.2B in revenue (up ~43% YoY), massive tangible book growth and improving cross-sell, but the stock dropped after management held adjusted EBITDA and EPS guidance. The fundamentals argue this is a durable fintech franchise; the market’s reaction opens a swing trade with asymmetric upside if cross-sell momentum contin…
NGL Energy Partners has turned its Water Solutions segment into a high-margin growth engine. With $660M adjusted EBITDA in 2026, a completed $950M refinancing, and management guidance of $715-$725M for 2027, the setup favors a re-rate. This trade targets share-price recovery and multiple expansion while respecting balance-sheet risk.
Enel's share price is carving higher on steady fundamentals and constructive technicals. With a market cap of $117.6B, a 2.42% yield and a P/E of 24.4, the stock looks positioned to continue a grid-led re-rating. This trade targets further upside while protecting capital on a defined stop.
Palantir reported $1.9B in Q2 revenue (93% YoY) and raised FY guidance to roughly $8.15B, signaling that enterprise AI adoption is accelerating beyond government work. The stock is richly valued, but momentum, improving fundamentals, and a still-small commercial AI penetration argue for a targeted long trade over the next 180 trading days with a st…
Freshworks is showing durable multi-product sales strength, positive cash flow, and improving profitability while trading at a reasonable multiple for a software company. We like a risk-defined long trade at current levels ($11.50) targeting a re-rating to $16.00 over a 180 trading-day horizon, with a stop at $9.75.
PayPal is trading near $58 with a $60.50 takeover proposal on the table that the board has already deemed inadequate. The company generates $6.6B in free cash flow and trades at roughly 7.6x P/FCF and ~11x P/E. I view $60 as too low; this idea lays out a long trade with entry, stop and targets tied to both a negotiated takeover path and operational…
Cass Information Systems reported strong earnings, healthy cash generation, and continues to return capital to shareholders. With EPS of $2.74, a $0.32 quarterly dividend, modest leverage and an expanding technical trend, I am upgrading my stance and laying out an actionable long trade with clear entry, stop and target.
Subaru (FUJHY) trades near the low end of its 52-week range with a sub-1.0 PB, a 3.5% yield and improving policy/tariff tailwinds. We upgrade to a Buy and lay out a mid-term (45 trading days) trade: entry $7.80, stop $7.10, target $10.50. Risk is real — tariff shifts, EV transition costs and heavy short activity can keep price volatile — but the ri…
Watsco (WSO) faces margin normalization after an outsized 2025 pricing tailwind, but cash flow, a conservative balance sheet, and e-commerce traction make the stock an attractive long-term trade. Enter on weakness with a defined stop and a 180-trading-day time horizon to capture margin recovery, acquisition synergies, and continued dividend compoun…
Nano Labs is a Hangzhou-based fabless semiconductor and AI compute solutions company trading at a $43.9M market cap. Recent strategic moves into AI data-center infrastructure and insider buying create a clear thesis for an asymmetric long trade. The stock is cheap on headline multiples, has a small float, and technicals show stabilizing momentum — …
Stoke Therapeutics looks buyable here on a mid-term swing basis. The setup combines improving clinical readouts, a concentrated short base, and technical momentum around $32.05. Valuation is aggressive but event-driven upside and a high short-interest backdrop make a disciplined long trade attractive for the next 45 trading days.
MPLX is a fee-driven midstream operator that sits close to its 52-week high but still offers a 7%+ yield, strong free cash flow, and a pipeline of expansion projects. This trade targets steady income and capital appreciation over a 180-trading-day horizon with a clear entry, stop and target.
Harmony Gold (HMY) combines deep-level South African assets, an open-pit footprint and a copper exposure that together position it to benefit from a sustained gold rally and rising margin tailwinds. At a market cap near $11.94B and a P/E of ~11.2, the stock still trades below prior cycle highs and offers asymmetric upside versus downside if bullion…
Booking Holdings trades at reasonable multiples vs. its cash generation and profitability. With FY2025 revenue of $26.9B, ~20% net margins and roughly $9B in free cash flow, a modest acceleration in earnings growth would drive the stock to sub-1x PEG territory. I’m initiating a long with a clear entry, stop and target and a mid-term horizon to capt…
Hut 8 has converted itself from a crypto miner into an AI and HPC infrastructure owner-operator, locking multi-year leases that imply tens of billions in contracted revenue. The market is pricing growth into the shares ($96.18 current), and while valuation is rich (market cap ~$11.3B, P/S ~36), the combination of long-duration contracted cash flows…
FMCB reported consecutive record quarters, increased its dividend to $5.35 quarterly and expanded buybacks — signals of durable profitability and capital discipline. The stock trades at $1,391.25 on OTC Link with bullish technical momentum but extremely light liquidity. This trade idea outlines a clear entry, stop and two targets across a 180-tradi…
HF Sinclair (DINO) is an attractive swing long while refined-product tightness persists. The company combines exposure to outsized crack spreads with low leverage, strong free cash flow ($2.24B), and an attractive valuation (P/E ~8.4, EV/EBITDA ~5.7). Enter at current levels, keep a clear stop below the 50-day moving average, and target the 52-week…
Accendra Health (ACH) trades at a sub-$250M market cap with heavy short interest, depressed technicals, and stretched negative sentiment ahead of Q2. Fundamentals are messy - negative EPS and large free cash flow deficits - but valuation metrics (price-to-sales, EV/EBITDA) and a deep float open the door for a mid-term rebound if the quarter shows s…
Freshworks is trading cheaply for a profitable SaaS company with accelerating AI productization. Recent product announcements and consistent FCF, combined with a modest P/E and a market cap near $3.4B, set up a favorable risk/reward. We lay out an actionable mid-term trade with entry, stop, and target, and highlight the key catalysts and risks that…
BlackLine appears to be past the trough in sentiment. The company is translating product investments into higher-value platform pricing, free cash flow remains healthy at $165M, and recent strategic moves (AI acquisition, institutional stake) set up a path to margin expansion. We recommend buying BL with an entry at $29.50, a stop at $26.00 and a t…
IBM ($235.80) looks like a reasonable mid-term (45 trading days) rebound candidate. The company offers a 2.9% yield, $13.8B in free cash flow and a below-peak valuation (P/E ~20.7) after a sharp pullback from the 52-week high. That said, growth is uneven—mainframe and infrastructure weakness has pressured revenue—and the trade requires a tight stop…
Ocular Therapeutix's AXPAXLI (OTX-TKI) presents a credible path from clinical success to durable commercial advantage in wet AMD. With Phase 3 data showing sustained durability, a $666.7M cash cushion and a $1.9B market cap, the stock offers asymmetric upside versus clear binary risks. This trade idea lays out entry, stop and target, catalysts to w…
AeroVironment (AVAV) has been punished by program setbacks and headline litigation, yet it still controls valuable niche capabilities in loitering munitions, small UAS and counter-UAS systems. With a $9.1B market cap, negative EPS but improving technicals and a clear runway in a growing military drone market, this trade targets a rebound to $240 ov…
OceanaGold is a high-beta gold producer that typically moves ahead of quarterly results. With the market likely pricing in cautious production guidance, an earnings beat or stronger gold pricing would be a clean catalyst for a 35-45% rebound. This trade uses a tight stop and two staged targets to capture a post-earnings re-rate while protecting cap…
John B. Sanfilippo & Son (JBSS) is a profitable, cash-generative specialty-nuts processor trading at a mid-teens P/E and an EV/EBITDA below 9. With EPS of $5.74, free cash flow near $49M and a $1.0B market cap, JBSS offers a mix of income (next payout on 08/17/2026) and upside if seasonal demand or ingredient-ingredient channels continue to outpace…
